(Q45398614)

English

Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial

scientific article published on 5 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial (English)

1 reference

Europe PubMed Central

14 December 2017

phase III clinical trial

0 references

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Y Onishi

1

1 reference

Europe PubMed Central

14 December 2017

Y Ono

2

1 reference

Europe PubMed Central

14 December 2017

R Rabøl

3

1 reference

Europe PubMed Central

14 December 2017

L Endahl

4

1 reference

Europe PubMed Central

14 December 2017

S Nakamura

5

1 reference

Europe PubMed Central

14 December 2017

publication date

5 April 2013

1 reference

Europe PubMed Central

14 December 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

14 December 2017

15

1 reference

Europe PubMed Central

14 December 2017

9

1 reference

Europe PubMed Central

14 December 2017

826-832

1 reference

Europe PubMed Central

14 December 2017

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Diabetes trends in Japan

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Metabolic control and diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Classification and treatment of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12097

21 January 2018

Identifiers

10.1111/DOM.12097

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45398614&oldid=2076579038"